Impact of .@healthgovau ‘s   . It’ll be well into 2022 before Australia reaches “safe”  levels &amp;  averted. Per @PharmaDispatch 
Supply constraint evident as Malaysia overtakes Australia at day 150 https://t.co/Uz65jFC5fd